Carsten Krantz

849 total citations
8 papers, 554 citations indexed

About

Carsten Krantz is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Carsten Krantz has authored 8 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Immunology. Recurrent topics in Carsten Krantz's work include Monoclonal and Polyclonal Antibodies Research (3 papers), Biosimilars and Bioanalytical Methods (2 papers) and Protein purification and stability (2 papers). Carsten Krantz is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (3 papers), Biosimilars and Bioanalytical Methods (2 papers) and Protein purification and stability (2 papers). Carsten Krantz collaborates with scholars based in Switzerland, United States and United Kingdom. Carsten Krantz's co-authors include Patrick Keller, Volker Nimmrich, John E. Harlan, Robert S. Bitner, Stefan Barghorn, Eve Barlow, Martin Schmidt, Heinz Hillen, Ulrich Ebert and Andreas Striebinger and has published in prestigious journals such as Journal of Neurochemistry, Organic Letters and Toxicologic Pathology.

In The Last Decade

Carsten Krantz

8 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carsten Krantz Switzerland 6 435 292 114 93 72 8 554
Isam Qahwash United States 8 458 1.1× 376 1.3× 94 0.8× 82 0.9× 81 1.1× 10 655
Andreas Striebinger Germany 6 599 1.4× 363 1.2× 162 1.4× 140 1.5× 96 1.3× 8 690
Monica M. Pallitto United States 5 557 1.3× 528 1.8× 124 1.1× 84 0.9× 47 0.7× 5 780
Andrew J. Beel United States 7 545 1.3× 672 2.3× 114 1.0× 109 1.2× 88 1.2× 10 988
Gerald Gellermann Germany 7 404 0.9× 475 1.6× 78 0.7× 41 0.4× 42 0.6× 9 638
Tamar Ziehm Germany 13 234 0.5× 174 0.6× 81 0.7× 61 0.7× 34 0.5× 18 354
Stephan Schilling Germany 16 333 0.8× 289 1.0× 73 0.6× 86 0.9× 96 1.3× 45 668
Sofia Söllvander Sweden 7 554 1.3× 375 1.3× 132 1.2× 79 0.8× 70 1.0× 7 737
Pascal Kuner Switzerland 7 271 0.6× 254 0.9× 47 0.4× 74 0.8× 105 1.5× 8 470
Charles Glabe United States 7 353 0.8× 265 0.9× 55 0.5× 69 0.7× 136 1.9× 10 604

Countries citing papers authored by Carsten Krantz

Since Specialization
Citations

This map shows the geographic impact of Carsten Krantz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carsten Krantz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carsten Krantz more than expected).

Fields of papers citing papers by Carsten Krantz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carsten Krantz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carsten Krantz. The network helps show where Carsten Krantz may publish in the future.

Co-authorship network of co-authors of Carsten Krantz

This figure shows the co-authorship network connecting the top 25 collaborators of Carsten Krantz. A scholar is included among the top collaborators of Carsten Krantz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carsten Krantz. Carsten Krantz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
2.
Yip, Richard, et al.. (2018). Development of an Automated, Interference-Free, 2D-Lc–Ms/Ms Assay for Quantification of a Therapeutic Mab in Human Sera. Bioanalysis. 10(13). 1023–1037. 10 indexed citations
3.
4.
Dudal, Sherri, Thierry Flandre, Philip J. Lowe, et al.. (2015). Integrated pharmacokinetic, pharmacodynamic and immunogenicity profiling of an anti-CCL21 monoclonal antibody in cynomolgus monkeys. mAbs. 7(5). 829–837. 13 indexed citations
5.
Krantz, Carsten, Christer Janson, Magnus P. Borres, et al.. (2014). Nasal nitric oxide is associated with exhaled NO, bronchial responsiveness and poor asthma control. Journal of Breath Research. 8(2). 26002–26002. 21 indexed citations
6.
Law, Wai Siang, et al.. (2014). Use of Generic LC–MS/MS Assays to Characterize Atypical PK Profile of A Biotherapeutic Monoclonal Antibody. Bioanalysis. 6(23). 3225–3235. 22 indexed citations
7.
Wagner, G., Vladimir B. Arion, Lothar Brecker, et al.. (2009). Controllable Selective Functionalization of a Cavitand via Solid State Photolysis of an Encapsulated Phenyl Azide. Organic Letters. 11(14). 3056–3058. 9 indexed citations
8.
Barghorn, Stefan, Volker Nimmrich, Andreas Striebinger, et al.. (2005). Globular amyloid β‐peptide1−42 oligomer − a homogenous and stable neuropathological protein in Alzheimer's disease. Journal of Neurochemistry. 95(3). 834–847. 471 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026